MEDIVATION $48.86

down -0.95


24/5/2013 04:24 PM  |  NASDAQ : MDVN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 13% - MDVN has underperformed the S&P 500 by 12%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Medivation Elects Kathryn Falberg to Board of Directors

    Benzinga

  2. Medivation Bulls Load Up on Call Options

    By SchaeffersResearch

  3. Aegis Capital Corp. Reiterates Buy Rating, $100 PT on Medivation

    Benzinga

  4. Medivation, Inc. (MDVN) President and CEO David Hung sells 10,246 ...

    GuruFocus

  5. Benzinga's Top Initiations

    Benzinga

  6. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    Investors Business Daily

  7. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus

  8. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Medivation

    Benzinga

  9. Medivation Effects 2-for-1 Stock Split

    Benzinga

  10. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga

  11. US FDA Approves XTANDI for Patients With Metastatic ...

    Benzinga

  12. Medivation Reports 2-for-1 Forward Split of Common Stock

    Benzinga

  13. Andreas Halvorsen Buys 2 Million Shares of Medivation

    GuruFocus

  14. Medivation Inc. (MDVN) President and CEO David Hung sells 25,000 ...

    GuruFocus

  15. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus

  16. Stocks Hitting 52-Week Highs

    Benzinga

  17. Health Care Sector Wrap

    FOXBusiness

  18. Four Winning Trades Based on Analyst Calls

    Benzinga

  19. Medivation Bull Looks to Cash In on Continued Rally

    By SchaeffersResearch

  20. Analyst Upgrades: MDVN, SCHN, and STI

    By SchaeffersResearch

  21. UPDATE: Wedbush Reiterates Outperform Rating, Raises PT for Medivation

    Benzinga

  22. Citigroup Reiterates Buy Rating, $129 PT for Medivation

    Benzinga

  23. Medivation and Astellas Announce Enzalutamide Data

    Benzinga

  24. Crazy Action in Medivation After Negative StreetSweeper Post

    Benzinga

  25. Global Fears and Small Caps: How Much of an Impact?

    Benzinga

  26. Social Media Outlook for Tuesday 15 (DKS, MDVN, BBY, ACOM)

    Benzinga

  27. GlaxoSmithKline, Vertex Point To Biotech Strength

    Investors Business Daily

  28. UPDATE: Wedbush Reiterates Outperform Rating, Raises PT for Medivation

    Benzinga

  29. Will Johnson & Johnson Cure Cancer?

    at Benzinga

  30. Options Players Show a Preference for Medivation Puts

    By SchaeffersResearch

  31. Notable Put Options Activity in Medivation

    at Benzinga

  32. Weekly CFO Sells Highlight: SLCA, UNH, LVS, RATE, MDVN, YUM, TER

    at GuruFocus

  33. Medivation's Stellar Technical Performance Entices Option Bulls

    By SchaeffersResearch

  34. Benzinga's M&A Chatter for Wednesday February 1, 2012

    at Benzinga

  35. Medivation Soars on Phase III Trial Data; Stock Up 21%

    at Benzinga

  36. Jefferies Raises PT on Medivation to $95

    at Benzinga

  37. Wedbush Raises PT on Medivation to $81

    at Benzinga

  38. Medivation and Astellas Announce Positive Results From the Phase 3 ...

    at Benzinga

  39. Upgrades & Downgrades: AZO, MDVN, POT, TSLA, and UA

    By SchaeffersResearch

  40. Gilead, Celgene Join Big Pharma On M&A Front

    at IBD

  41. Alzheimer's drug test halted

    at IBD

  42. Best Biotech Stocks of 2011

    at Benzinga

  43. Options Players Get Bearish with Medivation Puts

    By SchaeffersResearch

  44. Notable Put Options Activity in Medivation

    at Benzinga

  45. Put Volume Heats Up as Medivation Surges to a New High

    By SchaeffersResearch
People viewing MDVN also viewed: , , , , , ,
Marketplace
Trading Center